Axa S.A. Purchases 5,804 Shares of Ingredion Incorporated (NYSE:INGR)

Axa S.A. boosted its position in Ingredion Incorporated (NYSE:INGR - Free Report) by 31.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,055 shares of the company's stock after acquiring an additional 5,804 shares during the period. Axa S.A.'s holdings in Ingredion were worth $3,309,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC grew its position in shares of Ingredion by 31.9% during the 3rd quarter. Barclays PLC now owns 47,291 shares of the company's stock worth $6,499,000 after buying an additional 11,432 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in Ingredion during the 3rd quarter worth $149,000. Franklin Resources Inc. grew its holdings in Ingredion by 75.7% during the 3rd quarter. Franklin Resources Inc. now owns 194,295 shares of the company's stock worth $26,109,000 after acquiring an additional 83,708 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Ingredion by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 725,374 shares of the company's stock valued at $99,683,000 after purchasing an additional 10,812 shares during the period. Finally, GAMMA Investing LLC boosted its position in shares of Ingredion by 42.2% in the 4th quarter. GAMMA Investing LLC now owns 1,369 shares of the company's stock worth $188,000 after purchasing an additional 406 shares during the last quarter. 85.27% of the stock is currently owned by institutional investors and hedge funds.

Ingredion Price Performance

Shares of NYSE INGR opened at $135.65 on Thursday. The company has a fifty day moving average price of $131.43 and a 200 day moving average price of $135.55. The firm has a market cap of $8.72 billion, a PE ratio of 13.97, a PEG ratio of 1.03 and a beta of 0.73. The company has a current ratio of 2.62, a quick ratio of 1.69 and a debt-to-equity ratio of 0.47. Ingredion Incorporated has a 1-year low of $111.54 and a 1-year high of $155.44.

Ingredion (NYSE:INGR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $2.97 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.53. Ingredion had a return on equity of 18.62% and a net margin of 8.71%. The company had revenue of $1.81 billion during the quarter, compared to analysts' expectations of $1.84 billion. During the same period in the prior year, the firm earned $2.08 earnings per share. Ingredion's revenue for the quarter was down 3.7% compared to the same quarter last year. Research analysts predict that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.

Ingredion Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 22nd. Stockholders of record on Tuesday, April 1st were issued a $0.80 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.36%. Ingredion's dividend payout ratio (DPR) is presently 33.76%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on INGR. StockNews.com lowered Ingredion from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 6th. Oppenheimer reduced their price objective on shares of Ingredion from $167.00 to $155.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 22nd. UBS Group set a $155.00 target price on shares of Ingredion in a research note on Tuesday, April 22nd. Stephens reduced their price target on shares of Ingredion from $155.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 5th. Finally, BMO Capital Markets lowered their price objective on shares of Ingredion from $147.00 to $133.00 and set a "market perform" rating for the company in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.20.

Insider Transactions at Ingredion

In other Ingredion news, CEO James P. Zallie sold 10,815 shares of Ingredion stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total value of $1,361,392.20. Following the sale, the chief executive officer now directly owns 34,127 shares in the company, valued at approximately $4,295,906.76. The trade was a 24.06 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.30% of the stock is currently owned by insiders.

About Ingredion

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.